PATRICIA HALBROOK: Open Payments
NPI 1114520400 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 19 payments from 9 companies in 2025. Trend: 2023 $29 · 2024 $239 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 3 | $134 |
| Sage Therapeutics, LLC | 5 | $97 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $41 |
| Organon LLC | 1 | $28 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| MILLICENT US INC | 1 | $16 |
Products named: ZURZUVAE, MYOSURE TISSUE REMOVAL DEVICE, APTIMA, Qelbree, Veozah, NEXPLANON, Dexcom G6 Transmitter, MYFEMBREE.
Industry payments across TX — which companies pay providers there.
